215 related articles for article (PubMed ID: 16373258)
1. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus.
Nordmark G; Bengtsson C; Larsson A; Karlsson FA; Sturfelt G; Rönnblom L
Autoimmunity; 2005 Nov; 38(7):531-40. PubMed ID: 16373258
[TBL] [Abstract][Full Text] [Related]
2. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial.
Chang DM; Lan JL; Lin HY; Luo SF
Arthritis Rheum; 2002 Nov; 46(11):2924-7. PubMed ID: 12428233
[TBL] [Abstract][Full Text] [Related]
3. Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response.
Barry NN; McGuire JL; van Vollenhoven RF
J Rheumatol; 1998 Dec; 25(12):2352-6. PubMed ID: 9858429
[TBL] [Abstract][Full Text] [Related]
4. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
Petri MA; Lahita RG; Van Vollenhoven RF; Merrill JT; Schiff M; Ginzler EM; Strand V; Kunz A; Gorelick KJ; Schwartz KE;
Arthritis Rheum; 2002 Jul; 46(7):1820-9. PubMed ID: 12124866
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.
Diamond P; Cusan L; Gomez JL; Bélanger A; Labrie F
J Endocrinol; 1996 Sep; 150 Suppl():S43-50. PubMed ID: 8943786
[TBL] [Abstract][Full Text] [Related]
6. Dehydroepiandrosterone replacement in women with adrenal insufficiency.
Arlt W; Callies F; van Vlijmen JC; Koehler I; Reincke M; Bidlingmaier M; Huebler D; Oettel M; Ernst M; Schulte HM; Allolio B
N Engl J Med; 1999 Sep; 341(14):1013-20. PubMed ID: 10502590
[TBL] [Abstract][Full Text] [Related]
7. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months.
van Vollenhoven RF; Morabito LM; Engleman EG; McGuire JL
J Rheumatol; 1998 Feb; 25(2):285-9. PubMed ID: 9489820
[TBL] [Abstract][Full Text] [Related]
8. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial.
Johannsson G; Burman P; Wirén L; Engström BE; Nilsson AG; Ottosson M; Jonsson B; Bengtsson BA; Karlsson FA
J Clin Endocrinol Metab; 2002 May; 87(5):2046-52. PubMed ID: 11994339
[TBL] [Abstract][Full Text] [Related]
9. Studies of dehydroepiandrosterone (DHEA) as a therapeutic agent in systemic lupus erythematosus.
Van Vollenhoven RF; McGuire JL
Ann Med Interne (Paris); 1996; 147(4):290-6. PubMed ID: 8952750
[TBL] [Abstract][Full Text] [Related]
10. Hormones and lupus: defective dehydroepiandrosterone activity induces impaired interleukin-2 activity of T lymphocytes in patients with systemic lupus erythematosus.
Suzuki N; Suzuki T; Sakane T
Ann Med Interne (Paris); 1996; 147(4):248-52. PubMed ID: 8952743
[TBL] [Abstract][Full Text] [Related]
11. Changes in bone turnover markers and menstrual function after short-term oral DHEA in young women with anorexia nervosa.
Gordon CM; Grace E; Emans SJ; Goodman E; Crawford MH; Leboff MS
J Bone Miner Res; 1999 Jan; 14(1):136-45. PubMed ID: 9893076
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.
Vogl D; Falk W; Dorner M; Schölmerich J; Straub RH
J Rheumatol; 2003 Feb; 30(2):269-75. PubMed ID: 12563679
[TBL] [Abstract][Full Text] [Related]
13. [DHEA: orthodox or alternative medicine?].
Cogan E
Rev Med Brux; 2001 Sep; 22(4):A381-6. PubMed ID: 11680205
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.
van Vollenhoven RF; Park JL; Genovese MC; West JP; McGuire JL
Lupus; 1999; 8(3):181-7. PubMed ID: 10342710
[TBL] [Abstract][Full Text] [Related]
15. Effects of sex hormones on apoptosis in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Liu C; Zhou H; Qu R; Liu Z
Chin Med J (Engl); 2001 Mar; 114(3):291-3. PubMed ID: 11780316
[TBL] [Abstract][Full Text] [Related]
16. An open study of dehydroepiandrosterone in systemic lupus erythematosus.
van Vollenhoven RF; Engleman EG; McGuire JL
Arthritis Rheum; 1994 Sep; 37(9):1305-10. PubMed ID: 7945493
[TBL] [Abstract][Full Text] [Related]
17. DHEA: panacea or snake oil?
Sirrs SM; Bebb RA
Can Fam Physician; 1999 Jul; 45():1723-8. PubMed ID: 10424272
[TBL] [Abstract][Full Text] [Related]
18. [Is there an indication for dehydroepiandrosterone (DHEA) treatment in elderly women with Addison disease? Beneficial and adverse effects of DHEA].
Martin-Du Pan RC
Rev Med Suisse Romande; 2001 Sep; 121(9):649-54. PubMed ID: 11723706
[TBL] [Abstract][Full Text] [Related]
19. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
Hunt PJ; Gurnell EM; Huppert FA; Richards C; Prevost AT; Wass JA; Herbert J; Chatterjee VK
J Clin Endocrinol Metab; 2000 Dec; 85(12):4650-6. PubMed ID: 11134123
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of factors affecting quality of life in systemic lupus erythematosus.
Thumboo J; Fong KY; Chan SP; Leong KH; Feng PH; Thio ST; Boey ML
J Rheumatol; 2000 Jun; 27(6):1414-20. PubMed ID: 10852263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
